Skip to main content
. 2020 Mar;21(3):683–691. doi: 10.31557/APJCP.2020.21.3.683

Table 2.

The Association between BMI and Patients’ Characteristics and Tumor Characteristics

BMI n (%)
P value
Normal BMI n=36 High BMI (Obese) n=44
Menopausal Status
Premenopausal =16pt. 13 (36.1) 3 (6.8) 0.001
Postmenopausal =64pt. 23 (63.9) 41 (93.2)
Histopathology
IDC =75 pt 36 (100.0) 39 (88.6) 0.037
ILC =5 pt 0 (0.00) 5 (11.4)
Disease stage n (%)
I = 21 pt 12 (33.3) 9 (20.5)
II = 26 pt 11 (30.6) 15 (34.1) 0.5
IIIA = 33 pt 13 (36.1) 20 (45.4)
ER status
Positive =67 pt 26 (72.2) 41 (93.2) 0.011
Negative =13pt 10 (27.8) 3 (6.8)
PR status
Positive = 51 pt 24 (66.7) 27 (61.4) 0.62
Negative = 29 pt 12 (33.3) 17 (38.6)
HER2
Positive = 17 pt 4 (11.1) 13 (29.5) 0.045
Negative = 63 pt 32 (88.9) 31 (70.5)
Tumor grade n (%)
Low = 5 pt 3 (8.3) 2 (45.5) 0.76
Intermediate = 49 pt 21 (58.3) 28 (36.7)
High = 26 pt 12 (33.3) 14 (31.8)
LVI n (%) 10 (27.8) 16 (36.4) 0.42
Ki-67 (%) median (IQR) 15.0 (5.0 – 45.0) 35 (7.5 – 75.0) 0.11
Disease status/Treatment outcome
Relapse n (%) 4 (11.1) 10 (22.7) 0.16
Relapse time (months) 14.5 12.0 0.17
Median (IQR) (11.0 – 15.8) (11.0 - 13.0)
Survival time (months) 35.0 35.5 0.15
Median (IQR) (31.0 – 37.0) (34.0-36.0)
Mortality n (%) 1 (2.3) 6 (16.7) 0.023